Taisho Pharmaceutical focuses on the developing cold remedies and hair regrowth cosmetic products... Read more
Taisho Pharmaceutical focuses on the developing cold remedies and hair regrowth cosmetic products... Read more
CEO
Add
News
Jul 16, 2024
MarketScreener
Taisho Pharmaceutical Co., Ltd.: OASIS MANAGEMENT - CONFIRMS IT IS CONTESTING PRICE OF TAISHO PHA
Jul 14, 2024
Marketscreener
Taisho Pharmaceutical Co., Ltd.: Japan's Taisho Pharma faces claim over buyout price in court, Nikkei reports
Apr 05, 2024
NS Medical Devices
Taisho Pharmaceutical Co., Ltd.: Biolinq secures $58m funding to advance its wearable glucose biosensor
Apr 04, 2024
Medical Product Outsourcing
Taisho Pharmaceutical Co., Ltd.: Biolinq Raises $58M for Intradermal Glucose Sensor Pivotal Trial
Apr 04, 2024
BioSpace
Taisho Pharmaceutical Co., Ltd.: Biolinq Raises $58 Million to Advance Wearable Biosensors Through Pivotal Trial for Metabolic Health Using Precision Microsensor Technology
Mar 18, 2024
MarketScreener
Taisho Pharmaceutical Co., Ltd.: Curi RMB, Kaname to ask Tokyo court to revise Taisho Pharma squeeze-out price, Nikkei reports
Mar 08, 2024
Nasdaq
Taisho Pharmaceutical Co., Ltd.: Activist fund Oasis says it may take legal action over Taisho's management buyout
Feb 12, 2024
MarketScreener
Taisho Pharmaceutical Co., Ltd.: Oasis says it opposes Taisho Pharma's $5 bln management buyout
Jun 21, 2023
Benzinga
Taisho Pharmaceutical Co., Ltd.: Biolinq and Taisho Pharmaceutical Announce Strategic Collaboration and Exclusive License Agreement in Japan
Jun 21, 2023
Biospectrum Asia
Taisho Pharmaceutical Co., Ltd.: US-based Biolinq to commercialise new-gen glucose monitoring products in Japan, Read more